Mainstay Medical Receives US$108M Equity Financing

16 Feb, 2021

Mainstay Medical Receives US$108M Equity Financing
Photo by Vincent Garnier on Unsplash

– Mainstay Medical Holdings, a Dublin, Ireland-based medical device company focused on commercializing an innovative implantable restorative neurostimulation system for people with disabling mechanical Chronic Low Back Pain, closed an equity financing of US$108m.
– The round was co-led by new investors Ally Bridge Group and Sofinnova Partners, through its Crossover Fund, and also included a large, global medical device company.
– Key existing investors participating include Sofinnova Partners (Capital Fund), KCK Group and Fountain Healthcare Partners.

Biotechnology Emergency Medicine Europe Health Care Medical Medical Device
Crunchbase icon

Content report

The following text will be sent to our editors: